Literature DB >> 11451701

Prevalence of macrolide resistance genes in clinical isolates of the Streptococcus anginosus ("S. milleri") group.

J A Jacobs1, G J van Baar, N H London, J H Tjhie, L M Schouls, E E Stobberingh.   

Abstract

Twenty-two unrelated erythromycin-resistant anginosus group strains (3.2% resistance rate) were assessed for mechanisms of resistance. Streptococcus anginosus accounted for 16 of the 22 isolates. Fifteen isolates harbored the erm(B) gene. The erm(TR) and the mef(E) genes were carried by two isolates each. In three isolates, none of these resistance genes was detected by PCR.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11451701      PMCID： PMC90658          DOI： 10.1128/AAC.45.8.2375-2377.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  23 in total

Review 1.  Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification.

Authors:  R Leclercq; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

2.  Species belonging to the "Streptococcus milleri" group: antimicrobial susceptibility and comparative prevalence in significant clinical specimens.

Authors:  C Bantar; L Fernandez Canigia; S Relloso; A Lanza; H Bianchini; J Smayevsky
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

3.  Haemolytic activity of the Streptococcus milleri group' and relationship between haemolysis restricted to human red blood cells and pathogenicity in S. intermedius.

Authors:  J A Jacobs; C S Schot; L M Schouls
Journal:  J Med Microbiol       Date:  2000-01       Impact factor: 2.472

4.  Bacteriologic characteristics and antimicrobial susceptibility of 70 clinically significant isolates of Streptococcus milleri group.

Authors:  J L Gómez-Garcés; J I Alós; R Cogollos
Journal:  Diagn Microbiol Infect Dis       Date:  1994-06       Impact factor: 2.803

5.  Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland.

Authors:  H Seppälä; A Nissinen; Q Yu; P Huovinen
Journal:  J Antimicrob Chemother       Date:  1993-12       Impact factor: 5.790

6.  The Streptococcus anginosus species comprises five 16S rRNA ribogroups with different phenotypic characteristics and clinical relevance.

Authors:  J A Jacobs; C S Schot; L M Schouls
Journal:  Int J Syst Evol Microbiol       Date:  2000-05       Impact factor: 2.747

7.  In-vitro antimicrobial susceptibility of the "Streptococcus milleri' group (Streptococcus anginosus, Streptococcus constellatus and Streptococcus intermedius).

Authors:  J A Jacobs; E E Stobberingh
Journal:  J Antimicrob Chemother       Date:  1996-02       Impact factor: 5.790

8.  Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system.

Authors:  J Sutcliffe; A Tait-Kamradt; L Wondrack
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

9.  Identification of chromosomal antibiotic resistance genes in Streptococcus anginosus ("S. milleri").

Authors:  D Clermont; T Horaud
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

10.  Streptococcus anginosus, Streptococcus constellatus and Streptococcus intermedius. Clinical relevance, hemolytic and serologic characteristics.

Authors:  J A Jacobs; H G Pietersen; E E Stobberingh; P B Soeters
Journal:  Am J Clin Pathol       Date:  1995-11       Impact factor: 2.493
View more
  5 in total

1.  Genetic basis of erythromycin resistance in oral bacteria.

Authors:  A Villedieu; M L Diaz-Torres; A P Roberts; N Hunt; R McNab; D A Spratt; M Wilson; P Mullany
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

Review 2.  Molecular detection of the macrolide efflux gene: to discriminate or not to discriminate between mef(A) and mef(E).

Authors:  Corné H W Klaassen; Johan W Mouton
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

3.  Macrolide and clindamycin resistance in Streptococcus milleri group isolates from the airways of cystic fibrosis patients.

Authors:  Margot E Grinwis; Christopher D Sibley; Michael D Parkins; Christina S Eshaghurshan; Harvey R Rabin; Michael G Surette
Journal:  Antimicrob Agents Chemother       Date:  2010-04-19       Impact factor: 5.191

4.  In vitro activity of telithromycin against viridans group streptococci and Streptococcus bovis isolated from blood: antimicrobial susceptibility patterns in different groups of species.

Authors:  Iciar Rodríguez-Avial; Carmen Rodríguez-Avial; Esther Culebras; Juan J Picazo
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

5.  Molecular basis of resistance to macrolides and other antibiotics in commensal viridans group streptococci and Gemella spp. and transfer of resistance genes to Streptococcus pneumoniae.

Authors:  Paula Cerdá Zolezzi; Leticia Millán Laplana; Carmen Rubio Calvo; Pilar Goñi Cepero; Melisa Canales Erazo; Rafael Gómez-Lus
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.